258 related articles for article (PubMed ID: 9561482)
1. Molecular genetics of polycystic kidney disease.
Calvet JP
J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
3. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
Lantinga-van Leeuwen IS; Dauwerse JG; Baelde HJ; Leonhard WN; van de Wal A; Ward CJ; Verbeek S; Deruiter MC; Breuning MH; de Heer E; Peters DJ
Hum Mol Genet; 2004 Dec; 13(24):3069-77. PubMed ID: 15496422
[TBL] [Abstract][Full Text] [Related]
4. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).
Veldhuisen B; Spruit L; Dauwerse HG; Breuning MH; Peters DJ
Eur J Hum Genet; 1999 Dec; 7(8):860-72. PubMed ID: 10602361
[TBL] [Abstract][Full Text] [Related]
5. The genetics and physiology of polycystic kidney disease.
Calvet JP; Grantham JJ
Semin Nephrol; 2001 Mar; 21(2):107-23. PubMed ID: 11245774
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the human polycystic kidney disease 2 (PKD2) gene.
Deltas CC
Hum Mutat; 2001; 18(1):13-24. PubMed ID: 11438989
[TBL] [Abstract][Full Text] [Related]
7. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
[TBL] [Abstract][Full Text] [Related]
8. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.
Sutters M; Germino GG
J Lab Clin Med; 2003 Feb; 141(2):91-101. PubMed ID: 12577044
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
Wu G; Somlo S
Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
[TBL] [Abstract][Full Text] [Related]
10. Cellular pathophysiology of cystic kidney disease: insight into future therapies.
Avner ED; Woychik RP; Dell KM; Sweeney WE
Int J Dev Biol; 1999; 43(5):457-61. PubMed ID: 10535324
[TBL] [Abstract][Full Text] [Related]
11. Feline polycystic kidney disease mutation identified in PKD1.
Lyons LA; Biller DS; Erdman CA; Lipinski MJ; Young AE; Roe BA; Qin B; Grahn RA
J Am Soc Nephrol; 2004 Oct; 15(10):2548-55. PubMed ID: 15466259
[TBL] [Abstract][Full Text] [Related]
12. [Mutational analysis of the PKD1 and PKD2 (type 1 and 2 dominant autosomal polycystic kidney) genes].
Torra R; Badenas C; Pérez-Oller L; San Millán JL; Tellería D; Estivill X; Darnell A
Nefrologia; 2000; 20(1):39-46. PubMed ID: 10822721
[TBL] [Abstract][Full Text] [Related]
13. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease.
Stekrová J; Reiterová J; Merta M; Damborsky J; Zidovská J; Kebrdlová V; Kohoutová M
Nephrol Dial Transplant; 2004 May; 19(5):1116-22. PubMed ID: 14993477
[TBL] [Abstract][Full Text] [Related]
14. Polycystins, calcium signaling, and human diseases.
Delmas P; Padilla F; Osorio N; Coste B; Raoux M; Crest M
Biochem Biophys Res Commun; 2004 Oct; 322(4):1374-83. PubMed ID: 15336986
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
16. Polycystic kidney disease: new understanding in the pathogenesis.
Wilson PD
Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
[TBL] [Abstract][Full Text] [Related]
17. PKD1 interacts with PKD2 through a probable coiled-coil domain.
Qian F; Germino FJ; Cai Y; Zhang X; Somlo S; Germino GG
Nat Genet; 1997 Jun; 16(2):179-83. PubMed ID: 9171830
[TBL] [Abstract][Full Text] [Related]
18. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.
Hanaoka K; Qian F; Boletta A; Bhunia AK; Piontek K; Tsiokas L; Sukhatme VP; Guggino WB; Germino GG
Nature; 2000 Dec 21-28; 408(6815):990-4. PubMed ID: 11140688
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.
Badenas C; Torra R; Pérez-Oller L; Mallolas J; Talbot-Wright R; Torregrosa V; Darnell A
Eur J Hum Genet; 2000 Jul; 8(7):487-92. PubMed ID: 10909847
[TBL] [Abstract][Full Text] [Related]
20. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
